EAEPC attacks parallel trade report as "sheer propaganda tool," EAASM responds

3 December 2007

Heinz Kobelt, secretary general of the European parallel drug traders' association (EAEPC), has attacked the recent report on fake drugs from the European Alliance for Access to Safe Medicines (Marketletter November 26). Dr Kobelt said: "this kind of report makes no contribution to the patient safety debate. Published by an un-transparent, industry-funded 'patient safety alliance,' the report is about discrediting the legitimate and safe practice of European Union-internal distribution of medicines which introduces price competition for manufacturers."

He added that, "unfortunately, this kind of black propaganda risks distracting policymakers and the public from the real threats to patient health, such as illegal Internet sales of medicines. We would suggest that the report's author, Jonathan Harper, at least speak to or visit a parallel distributor before writing his next report on parallel trade."

EAASM's structure "is entirely transparent"

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight